Home > Research > Publications & Outputs > Therapeutic cloning: The ethical limits.

Research

Links

Text available via DOI:

Keywords

View graph of relations

Therapeutic cloning: The ethical limits.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Therapeutic cloning: The ethical limits. / Whittaker, Peter.
In: Toxicology and Applied Pharmacology, Vol. 207, No. 2, 09.2005, p. 689-691.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Whittaker, P 2005, 'Therapeutic cloning: The ethical limits.', Toxicology and Applied Pharmacology, vol. 207, no. 2, pp. 689-691. https://doi.org/10.1016/j.taap.2004.11.034

APA

Whittaker, P. (2005). Therapeutic cloning: The ethical limits. Toxicology and Applied Pharmacology, 207(2), 689-691. https://doi.org/10.1016/j.taap.2004.11.034

Vancouver

Whittaker P. Therapeutic cloning: The ethical limits. Toxicology and Applied Pharmacology. 2005 Sept;207(2):689-691. doi: 10.1016/j.taap.2004.11.034

Author

Whittaker, Peter. / Therapeutic cloning: The ethical limits. In: Toxicology and Applied Pharmacology. 2005 ; Vol. 207, No. 2. pp. 689-691.

Bibtex

@article{abecdcb2d8e74f25a5b50c8bad485d33,
title = "Therapeutic cloning: The ethical limits.",
abstract = "A brief outline of stem cells, stem cell therapy and therapeutic cloning is given. The position of therapeutic cloning with regard to other embryonic manipulations – IVF-based reproduction, embryonic stem formation from IVF embryos and reproductive cloning – is indicated. The main ethically challenging stages in therapeutic cloning are considered to be the nuclear transfer process including the source of eggs for this and the destruction of an embryo to provide stem cells for therapeutic use. The extremely polarised nature of the debate regarding the status of an early human embryo is noted, and some potential alternative strategies for preparing immunocompatible pluripotent stem cells are indicated.",
keywords = "Therapeutic cloning, Stem cells, Ethics",
author = "Peter Whittaker",
year = "2005",
month = sep,
doi = "10.1016/j.taap.2004.11.034",
language = "English",
volume = "207",
pages = "689--691",
journal = "Toxicology and Applied Pharmacology",
issn = "1096-0333",
publisher = "Academic Press Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Therapeutic cloning: The ethical limits.

AU - Whittaker, Peter

PY - 2005/9

Y1 - 2005/9

N2 - A brief outline of stem cells, stem cell therapy and therapeutic cloning is given. The position of therapeutic cloning with regard to other embryonic manipulations – IVF-based reproduction, embryonic stem formation from IVF embryos and reproductive cloning – is indicated. The main ethically challenging stages in therapeutic cloning are considered to be the nuclear transfer process including the source of eggs for this and the destruction of an embryo to provide stem cells for therapeutic use. The extremely polarised nature of the debate regarding the status of an early human embryo is noted, and some potential alternative strategies for preparing immunocompatible pluripotent stem cells are indicated.

AB - A brief outline of stem cells, stem cell therapy and therapeutic cloning is given. The position of therapeutic cloning with regard to other embryonic manipulations – IVF-based reproduction, embryonic stem formation from IVF embryos and reproductive cloning – is indicated. The main ethically challenging stages in therapeutic cloning are considered to be the nuclear transfer process including the source of eggs for this and the destruction of an embryo to provide stem cells for therapeutic use. The extremely polarised nature of the debate regarding the status of an early human embryo is noted, and some potential alternative strategies for preparing immunocompatible pluripotent stem cells are indicated.

KW - Therapeutic cloning

KW - Stem cells

KW - Ethics

U2 - 10.1016/j.taap.2004.11.034

DO - 10.1016/j.taap.2004.11.034

M3 - Journal article

VL - 207

SP - 689

EP - 691

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 1096-0333

IS - 2

ER -